PubMed:10027623
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 37-47 | cell_type | denotes | leukocytes |
| T2 | 335-356 | cell_type | denotes | leukocyte populations |
| T3 | 358-382 | protein | denotes | steroid hormone receptor |
| T4 | 419-424 | protein | denotes | bcl-2 |
| T5 | 598-616 | protein | denotes | oestrogen receptor |
| T6 | 629-634 | protein | denotes | bcl-2 |
| T7 | 666-676 | cell_type | denotes | leukocytes |
| T8 | 854-869 | cell_type | denotes | Apoptotic cells |
| T9 | 992-1016 | protein | denotes | steroid hormone receptor |
| T10 | 1053-1058 | protein | denotes | bcl-2 |
| T11 | 1189-1205 | cell_type | denotes | CD56+ CD16- eGLs |
| T12 | 1379-1383 | cell_type | denotes | eGLs |
| T13 | 1440-1444 | cell_type | denotes | eGLs |
| T14 | 1563-1595 | cell_type | denotes | CD56+ CD16+ natural killer cells |
| T15 | 1597-1601 | cell_type | denotes | eGLs |
| T16 | 1711-1724 | protein | denotes | interleukin-2 |
| T17 | 1759-1763 | cell_type | denotes | eGLs |
| T18 | 1892-1903 | cell_type | denotes | CD+8 T-cell |
| T19 | 1926-1944 | protein | denotes | oestrogen receptor |
| T20 | 1949-1954 | protein | denotes | bcl-2 |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 10027623-2#135#140#gene596 | 419-424 | gene596 | denotes | bcl-2 |
| 10027623-2#234#245#diseaseC0341858 | 518-529 | diseaseC0341858 | denotes | adenomyosis |
| 10027623-7#236#240#gene2214 | 1569-1573 | gene2214 | denotes | CD16 |
| 10027623-7#236#240#gene2215 | 1569-1573 | gene2215 | denotes | CD16 |
| 10027623-7#378#391#gene3558 | 1711-1724 | gene3558 | denotes | interleukin-2 |
| 10027623-7#303#318#diseaseC0747845 | 1636-1651 | diseaseC0747845 | denotes | early pregnancy |
| 10027623-8#120#125#gene596 | 1949-1954 | gene596 | denotes | bcl-2 |
| 10027623-8#204#217#diseaseC0014175 | 2033-2046 | diseaseC0014175 | denotes | endometriosis |
| 135#140#gene596234#245#diseaseC0341858 | 10027623-2#135#140#gene596 | 10027623-2#234#245#diseaseC0341858 | associated_with | bcl-2,adenomyosis |
| 236#240#gene2214303#318#diseaseC0747845 | 10027623-7#236#240#gene2214 | 10027623-7#303#318#diseaseC0747845 | associated_with | CD16,early pregnancy |
| 236#240#gene2215303#318#diseaseC0747845 | 10027623-7#236#240#gene2215 | 10027623-7#303#318#diseaseC0747845 | associated_with | CD16,early pregnancy |
| 378#391#gene3558303#318#diseaseC0747845 | 10027623-7#378#391#gene3558 | 10027623-7#303#318#diseaseC0747845 | associated_with | interleukin-2,early pregnancy |
| 120#125#gene596204#217#diseaseC0014175 | 10027623-8#120#125#gene596 | 10027623-8#204#217#diseaseC0014175 | associated_with | bcl-2,endometriosis |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 73-86 | NP | denotes | endometriosis |
| C1 | 0-86 | NP | denotes | Phenotypic and functional studies of leukocytes in human endometrium and endometriosis |
| C3 | 105-118 | NP | denotes | endometriosis |
| C4 | 120-151 | NP | denotes | a common and disabling disorder |
| C5 | 284-297 | NP | denotes | These studies |
| C6 | 335-356 | NP | denotes | leukocyte populations |
| C8 | 419-435 | NP | denotes | bcl-2 expression |
| C7 | 358-449 | NP | denotes | steroid hormone receptor expression, proliferative activity, bcl-2 expression and apoptosis |
| C9 | 501-514 | NP | denotes | endometriosis |
| C10 | 553-572 | NP | denotes | the menstrual cycle |
| C11 | 736-749 | NP | denotes | endometriosis |
| C12 | 755-802 | NP | denotes | CD56+ endometrial granulated lymphocytes (eGLs) |
| C13 | 940-953 | NP | denotes | endometriosis |
| C14 | 1102-1121 | NP | denotes | eutopic endometrium |
| C15 | 1440-1444 | NP | denotes | eGLs |
| C16 | 1450-1474 | NP | denotes | non-pregnant endometrium |
| C17 | 1482-1501 | NP | denotes | the menstrual cycle |
| C18 | 1522-1527 | NP | denotes | those |
| C19 | 1607-1631 | NP | denotes | non-pregnant endometrium |
| C20 | 1759-1763 | NP | denotes | eGLs |
| C21 | 1804-1827 | NP | denotes | the eutopic endometrium |
| C22 | 1829-1834 | NP | denotes | Their |
| C23 | 1949-1965 | NP | denotes | bcl-2 expression |
| C24 | 2033-2046 | NP | denotes | endometriosis |
| R1 | C3 | C2 | coref-ident | endometriosis,endometriosis |
| R2 | C4 | C3 | coref-appos | a common and disabling disorder,endometriosis |
| R3 | C5 | C1 | coref-ident | These studies,Phenotypic and functional studies of leukocytes in human endometrium and endometriosis |
| R4 | C7 | C6 | coref-appos | "steroid hormone receptor expression, proliferative activity, bcl-2 expression and apoptosis",leukocyte populations |
| R5 | C9 | C3 | coref-ident | endometriosis,endometriosis |
| R6 | C11 | C9 | coref-ident | endometriosis,endometriosis |
| R7 | C13 | C11 | coref-ident | endometriosis,endometriosis |
| R8 | C15 | C12 | coref-ident | eGLs,CD56+ endometrial granulated lymphocytes (eGLs) |
| R9 | C17 | C10 | coref-ident | the menstrual cycle,the menstrual cycle |
| R10 | C18 | C15 | coref-pron | those,eGLs |
| R11 | C19 | C16 | coref-ident | non-pregnant endometrium,non-pregnant endometrium |
| R12 | C20 | C18 | coref-ident | eGLs,those |
| R13 | C21 | C14 | coref-ident | the eutopic endometrium,eutopic endometrium |
| R14 | C22 | C20 | coref-pron | Their,eGLs |
| R15 | C23 | C8 | coref-ident | bcl-2 expression,bcl-2 expression |
| R16 | C24 | C13 | coref-ident | endometriosis,endometriosis |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-87 | Sentence | denotes | Phenotypic and functional studies of leukocytes in human endometrium and endometriosis. |
| S2 | 88-283 | Sentence | denotes | The aetiology of endometriosis, a common and disabling disorder, is presently unknown, although immune dysfunction could allow ectopic endometrial fragments to survive outside the uterine cavity. |
| S3 | 284-573 | Sentence | denotes | These studies investigate the relationship between leukocyte populations, steroid hormone receptor expression, proliferative activity, bcl-2 expression and apoptosis in eutopic and ectopic endometrium from women with endometriosis or adenomyosis at different phases of the menstrual cycle. |
| S4 | 574-853 | Sentence | denotes | Significantly increased oestrogen receptor expression, bcl-2 expression and numbers of CD8+ leukocytes were found in ectopic compared with eutopic endometrium in endometriosis, and CD56+ endometrial granulated lymphocytes (eGLs) were significantly reduced in ectopic endometrium. |
| S5 | 854-922 | Sentence | denotes | Apoptotic cells were rarely found in control and subject endometria. |
| S6 | 923-1176 | Sentence | denotes | In contrast with endometriosis, adenomyotic lesions showed identical steroid hormone receptor expression, proliferative activity, bcl-2 expression and leukocyte subpopulations to eutopic endometrium, indicating different aetiologies for these disorders. |
| S7 | 1177-1332 | Sentence | denotes | The unusual CD56+ CD16- eGLs present in large numbers in late secretory phase eutopic endometrium were highly purified (>98%) by immunomagnetic separation. |
| S8 | 1333-1596 | Sentence | denotes | Except for a negligible cytotoxic activity of eGLs from early proliferative samples, cytotoxic activity of eGLs from non-pregnant endometrium during the menstrual cycle was comparable with those in peripheral blood, predominantly CD56+ CD16+ natural killer cells. |
| S9 | 1597-1758 | Sentence | denotes | eGLs from non-pregnant endometrium and early pregnancy showed a variable proliferative response to 5 and 100 U/ml interleukin-2 over 48-h and 120-h time courses. |
| S10 | 1759-1828 | Sentence | denotes | eGLs are evidently functionally important in the eutopic endometrium. |
| S11 | 1829-2047 | Sentence | denotes | Their absence in endometriotic lesions together with increased CD+8 T-cell numbers and increased oestrogen receptor and bcl-2 expression may have significant effects on the development and progression of endometriosis. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 37-47 | cell_type | denotes | leukocytes |
| T2 | 51-68 | tissue | denotes | human endometrium |
| T3 | 73-86 | other_name | denotes | endometriosis |
| T4 | 105-118 | other_name | denotes | endometriosis |
| T5 | 184-202 | other_name | denotes | immune dysfunction |
| T6 | 215-244 | tissue | denotes | ectopic endometrial fragments |
| T7 | 268-282 | body_part | denotes | uterine cavity |
| T8 | 335-356 | cell_type | denotes | leukocyte populations |
| T9 | 358-382 | protein_family_or_group | denotes | steroid hormone receptor |
| T10 | 395-417 | other_name | denotes | proliferative activity |
| T11 | 419-424 | protein_molecule | denotes | bcl-2 |
| T12 | 440-449 | other_name | denotes | apoptosis |
| T13 | 490-495 | multi_cell | denotes | women |
| T14 | 501-514 | other_name | denotes | endometriosis |
| T15 | 518-529 | other_name | denotes | adenomyosis |
| T16 | 557-572 | other_name | denotes | menstrual cycle |
| T17 | 598-616 | protein_family_or_group | denotes | oestrogen receptor |
| T18 | 629-634 | protein_molecule | denotes | bcl-2 |
| T19 | 666-676 | cell_type | denotes | leukocytes |
| T20 | 691-698 | tissue | denotes | ectopic |
| T21 | 713-732 | tissue | denotes | eutopic endometrium |
| T22 | 736-749 | other_name | denotes | endometriosis |
| T23 | 833-852 | tissue | denotes | ectopic endometrium |
| T24 | 854-869 | cell_type | denotes | Apoptotic cells |
| T25 | 911-921 | tissue | denotes | endometria |
| T26 | 940-953 | other_name | denotes | endometriosis |
| T27 | 955-974 | tissue | denotes | adenomyotic lesions |
| T28 | 992-1016 | protein_family_or_group | denotes | steroid hormone receptor |
| T29 | 1029-1051 | other_name | denotes | proliferative activity |
| T30 | 1053-1058 | protein_molecule | denotes | bcl-2 |
| T31 | 1102-1121 | tissue | denotes | eutopic endometrium |
| T32 | 1189-1205 | cell_type | denotes | CD56+ CD16- eGLs |
| T33 | 1255-1274 | tissue | denotes | eutopic endometrium |
| T34 | 1306-1331 | other_name | denotes | immunomagnetic separation |
| T35 | 1346-1375 | other_name | denotes | negligible cytotoxic activity |
| T36 | 1379-1383 | cell_type | denotes | eGLs |
| T37 | 1418-1436 | other_name | denotes | cytotoxic activity |
| T38 | 1440-1444 | cell_type | denotes | eGLs |
| T39 | 1486-1501 | other_name | denotes | menstrual cycle |
| T40 | 1563-1595 | cell_type | denotes | CD56+ CD16+ natural killer cells |
| T41 | 1597-1601 | cell_type | denotes | eGLs |
| T42 | 1607-1631 | tissue | denotes | non-pregnant endometrium |
| T43 | 1661-1692 | other_name | denotes | variable proliferative response |
| T44 | 1711-1724 | protein_molecule | denotes | interleukin-2 |
| T45 | 1759-1763 | cell_type | denotes | eGLs |
| T46 | 1808-1827 | tissue | denotes | eutopic endometrium |
| T47 | 1846-1867 | tissue | denotes | endometriotic lesions |
| T48 | 1892-1903 | cell_type | denotes | CD+8 T-cell |
| T49 | 1926-1944 | protein_family_or_group | denotes | oestrogen receptor |
| T50 | 1949-1954 | protein_molecule | denotes | bcl-2 |
| T51 | 2033-2046 | other_name | denotes | endometriosis |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 105-118 | HP_0030127 | denotes | endometriosis |
| T2 | 501-514 | HP_0030127 | denotes | endometriosis |
| T3 | 736-749 | HP_0030127 | denotes | endometriosis |
| T4 | 940-953 | HP_0030127 | denotes | endometriosis |
| T5 | 2033-2046 | HP_0030127 | denotes | endometriosis |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 1949-1954 | gene:596 | denotes | bcl-2 |
| T1 | 2033-2046 | disease:C0014175 | denotes | endometriosis |
| R1 | T0 | T1 | associated_with | bcl-2,endometriosis |